UBE2O as a key regulator of drug-induced erythropoiesis in the context of myelodysplastic syndromes
Beatrice Maffeo(University of Turin), Daniela Cilloni(University of Turin)
Cited by 0
Related Papers
Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
|New England Journal of Medicine|2005|644
High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 Trial
|Journal of Clinical Oncology|2013|168
Bcl‐xL represents a therapeutic target in Philadelphia negative myeloproliferative neoplasms
|Journal of Cellular and Molecular Medicine|2020|33
mTORC2 Is Activated under Hypoxia and Could Support Chronic Myeloid Leukemia Stem Cells
|International Journal of Molecular Sciences|2023|16